✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd.

BIOFILCHEM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹71 Cr.
P/E
25.22

Biofil Chemicals & Pharmaceuticals Ltd.

  • Biofil Chem & Pharma
  • Makers Laboratories
  • Dipna Pharma.

FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Shareprice

Biofil Chem & Pharma has given better returns compared to its competitors.
Biofil Chem & Pharma has grown at ~-6.0% over the last 3yrs while peers have grown at a median rate of -6.37%

Biofil Chem & Pharma is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Biofil Chem & Pharma is 25.22, while 3 year average PE is 155.
Also latest EV/EBITDA of Biofil Chem & Pharma is 130 while 3yr average is 90.03.

View FAQ's On Business

Growth Table

  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Balance Sheet

  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Cash Flow

  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Quarterly Results

  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Dipna Pharma.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Financials

Balance sheet of Biofil Chem & Pharma is moderately strong.

Yes, The net debt of Biofil Chem & Pharma is increasing.
Latest net debt of Biofil Chem & Pharma is ₹0.21 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹4.04 Crs.

Yes, profit is increasing.
The profit of Biofil Chem & Pharma is ₹2.8 Crs for TTM, ₹0.71 Crs for Mar 2024 and ₹0.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biofil Chem & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech